Bradley Foster & Sargent Inc. CT increased its holdings in Waters Corporation (NYSE:WAT) by 5.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,545 shares of the medical instruments supplier’s stock after buying an additional 582 shares during the period. Bradley Foster & Sargent Inc. CT’s holdings in Waters Corporation were worth $1,939,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Oppenheimer Asset Management Inc. raised its position in shares of Waters Corporation by 0.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after buying an additional 2 shares in the last quarter. Diversified Trust Co raised its position in shares of Waters Corporation by 0.4% in the second quarter. Diversified Trust Co now owns 1,285 shares of the medical instruments supplier’s stock valued at $236,000 after buying an additional 5 shares in the last quarter. Alps Advisors Inc. raised its position in shares of Waters Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 3,062 shares of the medical instruments supplier’s stock valued at $563,000 after buying an additional 8 shares in the last quarter. Cleararc Capital Inc. raised its position in shares of Waters Corporation by 0.6% in the first quarter. Cleararc Capital Inc. now owns 1,950 shares of the medical instruments supplier’s stock valued at $305,000 after buying an additional 11 shares in the last quarter. Finally, Creative Planning raised its position in shares of Waters Corporation by 1.6% in the first quarter. Creative Planning now owns 744 shares of the medical instruments supplier’s stock valued at $116,000 after buying an additional 12 shares in the last quarter. Institutional investors own 91.12% of the company’s stock.

Waters Corporation (WAT) opened at 183.03 on Monday. The firm has a market capitalization of $14.61 billion, a P/E ratio of 27.59 and a beta of 0.83. The stock’s 50 day moving average is $179.53 and its 200 day moving average is $171.37. Waters Corporation has a one year low of $133.35 and a one year high of $187.65.

Waters Corporation (NYSE:WAT) last posted its quarterly earnings data on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.05. The firm had revenue of $558.30 million for the quarter, compared to analysts’ expectations of $553.22 million. Waters Corporation had a net margin of 24.26% and a return on equity of 23.91%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the company posted $1.58 EPS. On average, equities research analysts predict that Waters Corporation will post $7.38 earnings per share for the current fiscal year.

Waters Corporation announced that its board has authorized a stock buyback plan on Thursday, May 11th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the medical instruments supplier to buy up to 7.3% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its stock is undervalued.

In other news, Director Christopher A. Kuebler sold 3,500 shares of the firm’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $179.67, for a total transaction of $628,845.00. Following the sale, the director now owns 17,849 shares in the company, valued at approximately $3,206,929.83. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Rohit Khanna sold 23,000 shares of the firm’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $186.90, for a total transaction of $4,298,700.00. Following the sale, the senior vice president now owns 27,077 shares in the company, valued at approximately $5,060,691.30. The disclosure for this sale can be found here. Company insiders own 5.07% of the company’s stock.

TRADEMARK VIOLATION WARNING: This story was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://theolympiareport.com/2017/09/04/bradley-foster-sargent-inc-ct-has-1-94-million-stake-in-waters-corporation-wat.html.

WAT has been the subject of several research analyst reports. Bank of America Corporation restated a “neutral” rating and set a $192.00 price objective (up from $180.00) on shares of Waters Corporation in a research report on Friday, July 21st. Wells Fargo & Company restated an “outperform” rating and set a $205.00 price objective (up from $195.00) on shares of Waters Corporation in a research report on Thursday, July 13th. Jefferies Group LLC restated a “hold” rating and set a $170.00 price objective on shares of Waters Corporation in a research report on Friday, July 14th. Zacks Investment Research downgraded shares of Waters Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Finally, Cowen and Company restated a “hold” rating and set a $190.00 price objective on shares of Waters Corporation in a research report on Friday, July 14th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $186.00.

Waters Corporation Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT).

Institutional Ownership by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.